Trilostane therapy for treatment of pituitary-dependent hyperadrenocorticism in 5 cats

Journal of Veterinary Internal Medicine

Volumn 18, Issue 2, 2004, Pages 160-164

  Neiger, Reto ^a,e   Witt, Angela L ^a   Noble, Ann ^b   German, Alexander J ^c,d  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b Paragon Veterinary Group   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Cushing disease; Endocrine; Hypercortisolemia; Steroid

Indexed keywords

TRILOSTANE;

ARTICLE; CAT DISEASE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ENDOCRINE FUNCTION TEST; HYPERADRENOCORTICISM; MEDICAL RESEARCH; NONHUMAN; PROGNOSIS; SURVIVAL TIME;

3-HYDROXYSTEROID DEHYDROGENASES; ADMINISTRATION, ORAL; ADRENOCORTICAL HYPERFUNCTION; ANIMALS; BLOOD CHEMICAL ANALYSIS; CAT DISEASES; CATS; DIHYDROTESTOSTERONE; ENZYME INHIBITORS; FEMALE; MALE; TREATMENT OUTCOME;

FELIDAE; FELIS CATUS;

EID: 1642274988     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<160:TTFTOP>2.0.CO;2     Document Type: Article

References (24)

1. Behrend EN, Kemppainen RJ. Adrenocortical disease. In: August JR, ed. Consultations in Feline Medicine, 4th ed. Philadelphia, PA: WB Saunders; 2001:159-168.
2. Nelson RW, Feldman EC, Smith MC. Hyperadrenocorticism in cats: Seven cases (1978-1987). J Am Vet Med Assoc 1988;193:245-250.
3. Duesburg CA, Nelson RW, Feldman EC, et al. Adrenalectomy for treatment of hyperadrenocorticism in cats: 10 cases (1988-1992). J Am Vet Med Assoc 1995;207:1066-1070.
4. Schwedes CS. Mitotane (o,p′-DDD) treatment in a cat with hyperadrenocorticism. J Small Anim Pract 1997;38:520-524.
5. Nelson RW, Feldman EC. Hyperadrenocorticism. In: August JR, ed. Consultations in Feline Medicine, 1st ed. Philadelphia, PA: WB Saunders; 1991:267-270.
6. Peterson ME. Endocrine disorders in cats: Four emerging diseases. Compend Cont Educ Pract Vet 1988;10:1353-1362.
7. Daley CA, Zerbe CA, Schick RO, Powers RD. Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds. J Am Vet Med Assoc 1993;202:956-960.
8. Watson PJ, Herrtage ME. Hyperadrenocorticism in six cats. J Small Anim Pract 1998;39:175-184.
9. Meij BP, Voorhout G, Van den Ingh TSGAM, Rijnberk A. Transphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in 7 cats. Vet Surg 2001;30:72-86.
10. Neiger R, Ramsey I, O'Connor J, et al. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2002; 150:799-804.
11. Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory test, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002;63:506-512.
12. Semple CG, Beastall GH, Gray CE, Thomson JA. Trilostane in the management of Cushing's syndrome. Acta Endocrinol 1983;102:107-110.
13. McGowan CM, Neiger R. Efficacy of trilostane for the treatment of equine Cushing's syndrome. Equine Vet J 2003;35:414-418.
14. Skelly BJ, Petrus D, Nicholls PK. Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat. J Small Anim Pract 2003;44:269-272.
15. Boag AK, Church D, Neiger R. Treatment of hyperprogesteronaemia in a cat with trilostane. J Small Anim Pract. In press.
16. Sparkes AH, Adam DT, Douthwaite JA, Gruffydd-Jones TJ. Assessment of adrenal function in cats: Response to intravenous synthetic ACTH. J Small Anim Pract 1990;31:1-4.
17. Schoeman JP, Evans HJ, Childs D, Herrtage ME. Cortisol response to two different doses of intravenous synthetic ACTH (tetracosactrin) in overweight cats. J Small Anim Pract 2000;41:552-557.
18. Zimmer C, Hörauf A, Reusch C. Ultrasonographic examination of the adrenal gland and evaluation of the hypophyseal-adrenal axis in 20 cats. J Small Anim Pract 2000;41:156-160.
19. Swift GA, Brown RH. Surgical treatment of Cushing's syndrome in the cat. Vet Rec 1976;99:374-375.
20. Syme HM, Scott-Moncrieff JC, Treadwell NG, et al. Hyperadrenocorticism associated with excessive sex hormone production by an adrenocortical tumor in two dogs. J Am Vet Med Assoc 2001;219:1725-1728.
21. Ristic JM, Ramsey IK, Heath EM, et al. The use of 17-hydroxyprogesterone in the diagnosis of canine hyperadrenocorticism. J Vet Intern Med 2002;16:433-439.
22. Chapman PS, Ede J, Evans H, et al. Evaluation of basal and post-ACTH serum 17-hydroxyprogesterone concentrations in the diagnosis of canine hyperadrenocorticism. Vet Rec. In press.
23. Neiger R, Campbell E. 24 hour cortisol values after trilostane therapy in dogs with hyperadrenocorticism. European Society of Veterinary Internal Medicine 10th Annual Congress, Neuchatel, Switzerland, September 14-16, 2000.
24. Ramsey I, McGrotty Y. The effect of trilostane on ACTH stimulation tests performed at two different times post treatment. European Society of Veterinary Internal Medicine 11th Annual Congress, Dublin, Ireland, September 5-8, 2001.